WALTON ALAN G

CIK 00012142739 companiesPASADENA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001214273

Recent Transactions

50 trades

Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2011-12-30+1,595→ 8,708 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2010-12-31+1,365→ 7,113 total
Sale
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2010-03-08$64.09/sh−1,400→ 5,748 total
Sale
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2010-03-08$64.08/sh−2,100→ 7,148 total
Sale
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2010-02-18$61.72/sh−3,500→ 9,248 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2010-01-04+1,574→ 12,748 total
Sale
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2009-11-13$59.42/sh−5,500→ 11,174 total
Sale
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2009-11-10$59.36/sh−2,500→ 16,674 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2009-06-12+34,722→ 34,722 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2009-06-12+10,000→ 10,000 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2009-01-01+1,658→ 19,174 total
Award
AVALON PHARMACEUTICALS INC
Common Stock
2008-01-02$3.32/sh+816→ 22,796 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common Stock
2008-01-01+1,500→ 16,516 total
Award
AVALON PHARMACEUTICALS INC
Common Stock
2007-10-01$5.50/sh+1,477→ 21,980 total
Award
AVALON PHARMACEUTICALS INC
Common Stock
2007-07-02$4.24/sh+3,243→ 20,503 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2007-06-15+3,994→ 3,994 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2007-06-15+10,000→ 10,000 total
Award
AVALON PHARMACEUTICALS INC
Stock Option (Right to Buy)
2007-06-07+1,486→ 1,486 total
Award
AVALON PHARMACEUTICALS INC
Stock Option (Right to Buy)
2006-12-26+6,700
Award
AVALON PHARMACEUTICALS INC
Common Stock
2006-10-02$2.57/sh+4,621→ 11,022 total
Award
AVALON PHARMACEUTICALS INC
Common Stock
2006-07-07$3.39/sh+3,503→ 3,503 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2006-06-13+16,637→ 16,637 total
Award
Ocata Therapeutics, Inc.
Employee Stock Optin (right to buy)
2006-04-20$1.35/sh+50,000→ 100,000 total
Award
Ocata Therapeutics, Inc.
Employee Stock Option (right to buy)
2006-01-26$2.04/sh+50,000→ 50,000 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common stock
2006-01-13+653→ 12,280 total
Award
AVALON PHARMACEUTICALS INC
Common Stock
2006-01-03$4.64/sh+3,098→ 3,098 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common stock
2006-01-01+1,200→ 11,627 total
Award
AVALON PHARMACEUTICALS INC
Stock Option (Right to Buy)
2005-10-26+10,000→ 10,000 total
Award
AVALON PHARMACEUTICALS INC
Stock Option (Right to Buy)
2005-10-26+6,000→ 6,000 total
Award
AVALON PHARMACEUTICALS INC
Stock Option (Right to Buy)
2005-10-26+2,750→ 2,750 total
Award
ALEXANDRIA REAL ESTATE EQUITIES, INC.$ARE
Common stock
2005-10-14+168→ 10,908 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−14,062→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+43,606→ 50,168 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−253,061→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−36,066→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−3,005→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+457,946→ 528,066 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+5,420→ 6,244 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−21,415→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−23,686→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−649→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−5,858→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−1,766→ 0 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+20,693→ 95,954 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+13,795→ 63,963 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+65,267→ 75,261 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−54,628→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−7,786→ 0 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+145,195→ 673,261 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−150,257→ 0 total

Companies

Recent Filings

Address

C/O ALEXANDRIA REAL ESTATE EQUITIES, INC 385 E. COLORADO BLVD., SUITE 299

PASADENA, CA, 91101

View on SEC.gov